P

Phathom Pharma (PHAT)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Phathom Pharma (PHAT)

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more

Open
USD4.02
High
USD4.17
Low
USD3.97
52 Week High
USD19.71
Monthly Return
-37.10%
Revenue
55M

Daily Vol.
32.00
Avg. Daily Vol.
1.28M
Market Cap.
281M
52 Week Low
3.81
Annual Return
-54.80%

Stock News

Q1 2025 Third Coast Bancshares Inc Earnings Call

Q1 2025 Third Coast Bancshares Inc Earnings Call

Yahoo

Making iPhones has gotten complicated in tariff wars. Apple reportedly has a plan to stop some sourcing from China.

Making iPhones has gotten complicated in tariff wars. Apple reportedly has a plan to stop some sourcing from China.

MarketWatch

Star Bulk Carriers: Trade Conflict May Permanently Reduce China's Dry Bulk Imports

Star Bulk Carriers: Trade Conflict May Permanently Reduce China's Dry Bulk Imports

SeekingAlpha

Rates Spark: Not Much Is Needed For More Dovish ECB Pricing

Rates Spark: Not Much Is Needed For More Dovish ECB Pricing

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.